Nicolas Caron, PhD
Research Associate, University of British Columbia , Dr. Michael Hayden
Multi-omic biomarker discovery for Huntington disease
Since HD starts damaging the brain years before symptoms appear, early treatment would be our best option. But without symptoms, how do we know how fast someone is progressing or whether a treatment is helping? Dr. Caron’s project will identify new biomarkers—molecules in cerebrospinal fluid—that could track these early changes and measure treatment effectiveness.
